Article Information
vol. 8 no. 1
PubMed
Published By
Online ISSN
History
- Received September 8, 2021
- Accepted January 29, 2022
- Published online March 14, 2022.
Article Versions
- previous version (March 2, 2022 - 07:51).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Huda Badri1,2⇑,
- Carmen Gibbard1,
- Dimitra Denton1,
- Imran Satia1,3,
- Bashar Al-Sheklly1,
- Rachel J. Dockry1,
- Kimberley Holt1,
- Kevin McGuiness4,
- Sam Treadway4,
- Peter Whorwell1,4,
- Lesley Houghton1,5,6,
- Augustine Lee7,
- K. Jane Escott8,
- Theresa Lee7,
- Greame Wilkinson9,
- Alison Holt9,
- Brendan J. Canning10 and
- Jacky A. Smith1,4
- 1Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK
- 2North Manchester General Hospital, Pennine Acute NHS Trust, Manchester, UK
- 3Dept of Medicine, Division of Respiratory Medicine, McMaster University, Hamilton, ON, Canada
- 4Wythenshawe Hospital, Manchester University Foundation Trust, Manchester, UK
- 5Division of Gastroenterology and Surgical Sciences, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK
- 6Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA
- 7Pulmonary Medicine, Mayo Clinic, Jacksonville, FL, USA
- 8Emerging Innovations, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
- 9AstraZeneca, Macclesfield, UK
- 10Johns Hopkins Asthma and Allergy Centre, Baltimore, MD, USA
- Corresponding author: Huda Badri (huda.badri{at}manchester.ac.uk)
Funding
Medical Research Council
Joint collaboration with AstraZeneca; MR/K015141/1